A genome-wide association meta-analysis on apolipoprotein A-IV concentrations

Human Molecular Genetics

Volumn 25, Issue 16, 2016, Pages 3635-3646

  Lamina, Claudia ^a   Friedel, Salome ^a   Coassin, Stefan ^a   Rueedi, Rico ^b,c   Yousri, Noha A ^d,e   Seppälä, Ilkka ^f   Gieger, Christian ^g   Schönherr, Sebastian ^a   Forer, Lukas ^a   Erhart, Gertraud ^a   Kollerits, Barbara ^a   Marques Vidal, Pedro ^h   Ried, Janina ^g   Waeber, Gerard ^h   Bergmann, Sven ^b,c   Dähnhardt, Doreen ^a   Stöckl, Andrea ^a   Kiechl, Stefan ^a   Raitakari, Olli T ^i,j   Kähönen, Mika ^f   Willeit, Johann ^a   Kedenko, Ludmilla ^k   Paulweber, Bernhard ^k   Peters, Annette ^g,l,m   Meitinger, Thomas ^g,n,o   Strauch, Konstantin ^g,p   Lehtimäki, Terho ^f   Hunt, Steven C ^d,q   Vollenweider, Peter ^h   Kronenberg, Florian ^a   more..

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^e Alexandria University The Faculty Of Engineering   (Egypt)

^f TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁱ TURKU UNIVERSITY HOSPITAL   (Finland)

^j UNIVERSITY OF TURKU   (Finland)

^k PARACELSUS MEDICAL UNIVERSITY   (Austria)

^l DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^m GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

ⁿ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^o Germany 3 Munich Cluster for Systems Neurology   (Germany)

^p UNIVERSITY OF MUNICH   (Germany)

^q UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV;

ALLELE; ARTICLE; CHROMOSOME 4; CHROMOSOME IDENTIFICATION; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; KIDNEY METABOLISM; KLKB1 GENE; MALE; META ANALYSIS (TOPIC); MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; GENETICS; KIDNEY; META ANALYSIS; METABOLISM;

ALLELES; APOLIPOPROTEINS A; CHOLESTEROL, HDL; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KIDNEY; LIPIDS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 85014304809     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw211     Document Type: Article

References (76)

1. Utermann, G. and Beisiegel, U. (1979) Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur. J. Biochem., 99, 333-343.
2. Wang, F., Kohan, A.B., Lo, C.M., Liu, M., Howles, P. and Tso, P. (2015) Apolipoprotein A-IV: a protein intimately involved in metabolism. J. Lipid Res., 56, 1403-1418.
3. Steinmetz, A., Barbaras, R., Ghalim, N., Clavey, V., Fruchart, J.C. and Ailhaud, G. (1990) Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J. Biol. Chem., 265, 7859-7863.
4. Stein, O., Stein, Y., Lefevre, M. and Roheim, P.S. (1986) The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim. Biophys. Acta, 878, 7-13.
5. Stoffel, W. (1984) Synthesis, transport, and processing of apolipoproteins of high density lipoproteins. J. Lipid Res., 25, 1586-1592.
6. Bisgaier, C.L., Sachdev, O.P., Megna, L. and Glickman, R.M. (1985) Distribution of apolipoprotein A-IV in human plasma. J. Lipid Res., 26, 11-25.
7. Duverger, N., Tremp, G., Caillaud, J.M., Emmanuel, F., Castro, G., Fruchart, J.C., Steinmetz, A. and Denèfle, P. (1996) Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science, 273, 966-968.
8. Cohen, R.D., Castellani, L.W., Qiao, J.H., Van Lenten, B.J., Lusis, A.J. and Reue, K. (1997) Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J. Clin. Invest., 99, 1906-1916.
9. Kronenberg, F., Stühlinger, M., Trenkwalder, E., Geethanjali, F.S., Pachinger, O., von Eckardstein, A. and Dieplinger, H. (2000) Lowapolipoprotein A-IV plasma concentrations inmen with coronary artery disease. J.Am. Coll. Cardiol., 36, 751-757.
10. Manpuya, M.W., Guo, J. and Zhao, Y. (2001) The relationship between plasma apolipoprotein A-IV levels and coronary heart disease. Chin. Med. J. (Engl), 114, 275-279.
11. Omori, M., Watanabe, M., Matsumoto, K., Honda, H., Hattori, H. and Akizawa, T. (2010) Impact of serum apolipoprotein AIV as a marker of cardiovascular disease in maintenance hemodialysis patients. Ther. Apher. Dial, 14, 341-348.
12. Li, J., Song, M., Qian, D., Lu, W., Wang, J., Jiang, G., Jin, J., Wu, X. and Huang, L. (2013) Decreased plasma apolipoprotein AIV levels in patients with acute coronary syndrome. Clin. Investig. Med. Médecine Clin. Exp., 36, E207-E215.
13. Kronenberg, F., Kuen, E., Ritz, E., König, P., Kraatz, G., Lhotta, K., Mann, J.F.E., Müller, G.A., Neyer, U., Riegel, W., et al. (2002) Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure. J. Am. Soc. Nephrol, 13, 461-469.
14. Stangl, S., Kollerits, B., Lamina, C., Meisinger, C., Huth, C., Stöckl, A., Dähnhardt, D., Böger, C.A., Krämer, B.K., Peters, A., et al. (2015) Association between apolipoprotein A-IV concentrations and chronic kidney disease in two large population-based cohorts: results from the KORA studies. J. Intern. Med., 278, 410-423.
15. Lingenhel, A., Lhotta, K., Neyer, U., Heid, I.M., Rantner, B., Kronenberg, M.F., König, P., von Eckardstein, A., Schober, M., Dieplinger, H., et al. (2006) Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria. J. Lipid Res., 47, 2071-2079.
16. Boes, E., Fliser, D., Ritz, E., König, P., Lhotta, K., Mann, J.F.E., Müller, G.A., Neyer, U., Riegel, W., Riegler, P., et al. (2006) Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study. J. Am. Soc. Nephrol., 17, 528-536.
17. Zaiou, M., Visvikis, S., Gueguen, R., Steinmetz, J., Parra, H.J., Fruchart, J.C. and Siest, G. (1994) Sources of variability of human plasma apolipoprotein A-IV levels and relationships with lipid metabolism. Genet. Epidemiol., 11, 101-114.
18. Gomaraschi, M., Putt, W.E., Pozzi, S., Iametti, S., Barbiroli, A., Bonomi, F., Favari, E., Bernini, F., Franceschini, G., Talmud, P.J., et al. (2010) Structure and function of the apoA-IV T347S and Q360H common variants. Biochem. Biophys. Res. Commun., 393, 126-130.
19. Larson, I.A., Ordovas, J.M., Sun, Z., Barnard, Lohrmann, J., Feussner, G., and Lamon-Fava, S, Schaefer, E.J. (2002) Effects of apolipoprotein A-IV genotype on glucose and plasma lipoprotein levels. Clin. Genet, 61, 430-436.
20. Wong, W.R., Hawe, E., Li, L.K., Miller, G.J., Nicaud, V., Pennacchio, L.A., Humphries, S.E. and Talmud, P.J. (2003) Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ. Res, 92, 969-975.
21. Talmud, P.J., Hawe, E., Martin, S., Olivier, M., Miller, G.J., Rubin, E.M., Pennacchio, L.A. and Humphries, S.E. (2002) Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet., 11, 3039-3046.
22. Hubacek, J.A., Skodova, Z., Adamkova, V., Vrablik, M., Horinek, A., Lanska, V., Ceska, R. and Poledne, R. (2003) Apolipoprotein AV gene polymorphisms (T-1131/C and Ser19/Trp) influence plasma triglyceride levels and risk of myocardial infarction. Exp. Clin. Cardiol., 8, 151-154.
23. Ehnholm, C., Tenkanen, H., de Knijff, P., Havekes, L., Rosseneu, M., Menzel, H.J. and Tiret, L. (1994) Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. Atherosclerosis, 107, 229-238.
24. Willer, C.J., Schmidt, E.M., Sengupta, S., Peloso, G.M., Gustafsson, S., Kanoni, S., Ganna, A., Chen, J., Buchkovich, M.L., Mora, S., et al. (2013) Discovery and refinement of loci associated with lipid levels. Nat. Genet, 45, 1274-1283.
25. Ou, H.J., Huang, G., Liu, W., Ma, X.L., Wei, Y., Zhou, T. and Pan, Z.M. (2015) Relationship of the APOA5/A4/C3/A1 gene cluster and APOB gene polymorphisms with dyslipidemia. Genet. Mol. Res., 14, 9277-9290.
26. Delgado-Lista, J., Perez-Jimenez, F., Ruano, J., Perez-Martinez, P., Fuentes, F., Criado-Garcia, J., Parnell, L.D., Garcia-Rios, A., Ordovas, J.M. and Lopez-Miranda, J. (2010) Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men. J. Lipid Res., 51, 63-73.
27. Liu, Y., Ordovas, J.M., Gao, G., Province, M., Straka, R.J., Tsai, M.Y., Lai, C.Q., Zhang, K., Borecki, I., Hixson, J.E., et al. (2009) Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study. Pharmacogenet. Genomics, 19, 161-169.
28. Wuepper, K.D. (1973) Prekallikrein deficiency in man. J. Exp. Med., 138, 1345-1355.
29. Colman, R.W. (1999) Biologic activities of the contact factors in vivo-potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thromb. Haemost., 82, 1568-1577.
30. Schmaier, A.H. (2002) The plasma kallikrein-kinin system counterbalances the renin-angiotensin system. J. Clin. Invest., 109, 1007-1009.
31. Shin, S.Y., Fauman, E.B., Petersen, A.K., Krumsiek, J., Santos, R., Huang, J., Arnold, M., Erte, I., Forgetta, V., Yang, T.P., et al. (2014) An atlas of genetic influences on human blood metabolites. Nat. Genet., 46, 543-550.
32. Suhre, K., Shin, S.Y., Petersen, A.K., Mohney, R.P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., Grundberg, E., et al. (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature, 477, 54-60.
33. Biswas, N., Maihofer, A.X., Mir, S.A., Rao, F., Zhang, K., Khandrika, S., Mahata, M., Friese, R.S., Hightower, C.M., Mahata, S.K., et al. (2016) Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system. BMC Med. Genet., 17, 21.
34. Musani, S.K., Fox, E.R., Kraja, A., Bidulescu, A., Lieb, W., Lin, H., Beecham, A., Chen, M.H., Felix, J.F., Fox, C.S., et al. (2015) Genome-wide association analysis of plasma B-type natriuretic peptide in blacks: the Jackson Heart Study. Circ. Cardiovasc. Genet., 8, 122-130.
35. Verweij, N., Mahmud, H., Mateo Leach, I., de Boer, R.A., Brouwers, F.P., Yu, H., Asselbergs, F.W., Struck, J., Bakker, S.J.L., Gansevoort, R.T., et al. (2013) Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1. Hypertension, 61, 602-608.
36. Björkqvist, J., Jämsä, A. and Renné, T. (2013) Plasma kallikrein: the bradykinin-producing enzyme. Thromb. Haemost., 110, 399-407.
37. Nakano, M., Kelly, E.J., Wiek, C., Hanenberg, H. and Rettie, A.E. (2012) CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of x-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Mol. Pharmacol., 82, 679-686.
38. Nakano, M., Kelly, E.J. and Rettie, A.E. (2009) Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase. Drug Metab. Dispos., 37, 2119-2122.
39. Li, A., Jiao, X., Munier, F.L., Schorderet, D.F., Yao, W., Iwata, F., Hayakawa, M., Kanai, A., Shy Chen, M., Alan Lewis, R., et al. (2004) Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am. J. Hum. Genet., 74, 817-826.
40. Teslovich, T.M., Musunuru, K., Smith, A.V., Edmondson, A.C., Stylianou, I.M., Koseki, M., Pirruccello, J.P., Ripatti, S., Chasman, D.I., Willer, C.J., et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466, 707-713.
41. Waterworth, D.M., Ricketts, S.L., Song, K., Chen, L., Zhao, J.H., Ripatti, S., Aulchenko, Y.S., Zhang, W., Yuan, X., Lim, N., et al. (2010) Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 30, 2264-2276.
42. Dichgans, M., Malik, R., König, I.R., Rosand, J., Clarke, R., Gretarsdottir, S., Thorleifsson, G., Mitchell, B.D., Assimes, T.L., Levi, C., et al. (2014) Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke, 45, 24-36.
43. Schunkert, H., König, I.R., Kathiresan, S., Reilly, M.P., Assimes, T.L., Holm, H., Preuss, M., Stewart, A.F.R., Barbalic, M., Gieger, C., et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet., 43, 333-338.
44. Do, R., Willer, C.J., Schmidt, E.M., Sengupta, S., Gao, C., Peloso, G.M., Gustafsson, S., Kanoni, S., Ganna, A., Chen, J., et al. (2013) Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet., 45, 1345-1352.
45. Pattaro, C., Teumer, A., Gorski, M., Chu, A.Y., Li, M., Mijatovic, V., Garnaas, M., Tin, A., Sorice, R., Li, Y., et al. (2016) Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat. Commun., 7, 10023.
46. Kronenberg, F., König, P., Neyer, U., Auinger, M., Pribasnig, A., Lang, U., Reitinger, J., Pinter, G., Utermann, G. and Dieplinger, H. (1995) Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J. Am. Soc. Nephrol., 6, 110-120.
47. Lagrost, L., Gambert, P., Meunier, S., Morgado, P., Desgres, J., d'Athis, P. and Lallemant, C. (1989) Correlation between apolipoprotein A-IV and triglyceride concentrations in human sera. J. Lipid Res., 30, 701-710.
48. Kohan, A.B., Wang, F., Lo, C.M., Liu, M. and Tso, P. (2015) ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety. Am. J. Physiol. Gastrointest. Liver Physiol., 308, G472-G481.
49. Hanniman, E.A., Lambert, G., Inoue, Y., Gonzalez, F.J. and Sinal, C.J. (2006) Apolipoprotein A-IV is regulated by nutritional and metabolic stress: involvement of glucocorticoids, HNF-4 alpha, and PGC-1 alpha. J. Lipid Res., 47, 2503-2514.
50. Benjamini, Y. and Hochberg, Y. (1995) Controlling The False Discovery Rate-A Practical And Powerful Approach To Multiple Testing. J. R. Stat. Soc. Ser. B Methodol., 57, 289-300.
51. Firmann, M., Mayor, V., Vidal, P.M., Bochud, M., Pécoud, A., Hayoz, D., Paccaud, F., Preisig, M., Song, K.S., Yuan, X., et al. (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc. Disord., 8, 6.
52. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. and Abecasis, G.R. (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet., 44, 955-959.
53. Higgins, M., Province, M., Heiss, G., Eckfeldt, J., Ellison, R.C., Folsom, A.R., Rao, D.C., Sprafka, J.M. and Williams, R. (1996) NHLBI Family Heart Study: objectives and design. Am. J. Epidemiol., 143, 1219-1228.
54. Li, Y., Willer, C.J., Ding, J., Scheet, P. and Abecasis, G.R. (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol., 34, 816-834.
55. Marchini, J., Howie, B., Myers, S., McVean, G. and Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet., 39, 906-913.
56. Heid, I.M., Boes, E., Müller, M., Kollerits, B., Lamina, C., Coassin, S., Gieger, C., Döring, A., Klopp, N., Frikke-Schmidt, R., et al. (2008) Genome-wide association analysis of highdensity lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions. Circ. Cardiovasc. Genet., 1, 10-20.
57. Raitakari, O.T., Juonala, M., Rönnemaa, T., Keltikangas-Järvinen, L., Räsänen, L., Pietikäinen, M., Hutri-Kähönen, N., Taittonen, L., Jokinen, E., Marniemi, J., et al. (2008) Cohort profile: the cardiovascular risk in Young Finns Study. Int. J. Epidemiol., 37, 1220-1226.
58. Kronenberg, F., Kronenberg, M.F., Kiechl, S., Trenkwalder, E., Santer, P., Oberhollenzer, F., Egger, G., Utermann, G. and Willeit, J. (1999) Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation, 100, 1154-1160.
59. Kiechl, S., Willeit, J., Mayr, M., Viehweider, B., Oberhollenzer, M., Kronenberg, F., Wiedermann, C.J., Oberthaler, S., Xu, Q., Witztum, J.L., et al. (2007) Oxidized phospholipids, lipoprotein( a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Arterioscler. Thromb. Vasc. Biol., 27, 1788-1795.
60. Heid, I.M., Wagner, S.A., Gohlke, H., Iglseder, B., Mueller, J.C., Cip, P., Ladurner, G., Reiter, R., Stadlmayr, A., Mackevics, V., et al. (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1, 727 healthy Caucasians. Diabetes, 55, 375-384.
61. Kronenberg, F., Lobentanz, E.M., König, P., Utermann, G. and Dieplinger, H. (1994) Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J. Lipid Res., 35, 1318-1328.
62. Behrens, G., Winkler, T.W., Gorski, M., Leitzmann, M.F. and Heid, I.M. (2011) To stratify or not to stratify: power considerations for population-based genome-wide association studies of quantitative traits. Genet. Epidemiol., 35, 867-879.
63. Winkler, T.W., Day, F.R., Croteau-Chonka, D.C., Wood, A.R., Locke, A.E., Mägi, R., Ferreira, T., Fall, T., Graff, M., Justice, A.E., et al. (2014) Quality control and conduct of genomewide association meta-analyses. Nat. Protoc., 9, 1192-1212.
64. Han, B. and Eskin, E. (2011) Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am. J. Hum. Genet., 88, 586-598.
65. Pruim, R.J., Welch, R.P., Sanna, S., Teslovich, T.M., Chines, P.S., Gliedt, T.P., Boehnke, M., Abecasis, G.R. and Willer, C.J. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics, 26, 2336-2337.
66. Yang, J., Lee, S.H., Goddard, M.E. and Visscher, P.M. (2011) GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet., 88, 76-82.
67. Li, M.X., Sham, P.C., Cherny, S.S. and Song, Y.Q. (2010) A knowledge-based weighting framework to boost the power of genome-wide association studies. PLoS One, 5, e14480.
68. Li, M.X., Gui, H.S., Kwan, J.S.H. and Sham, P.C. (2011) GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am. J. Hum. Genet., 88, 283-293.
69. Li, M.X., Kwan, J.S.H. and Sham, P.C. (2012) HYST: a hybrid set-based test for genome-wide association studies, with application to protein-protein interaction-based association analysis. Am. J. Hum. Genet., 91, 478-488.
70. de Los Campos, G., Sorensen, D. and Gianola, D. (2015) Genomic heritability: what is it? PLoS Genet., 11, e1005048.
71. Pattaro, C., Teumer, A., Gorski, M., Chu, A.Y., Li, M., Mijatovic, V., Garnaas, M., Tin, A., Sorice, R., Li, Y., et al. (2016) Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat. Commun., 7, 10023.
72. Lamina, C., Coassin, S., Illig, T. and Kronenberg, F. (2011) Look beyond one's own nose: combination of information from publicly available sources reveals an association of GATA4 polymorphisms with plasma triglycerides. Atherosclerosis, 219, 698-703.
73. Adzhubei, I., Jordan, D.M. and Sunyaev, S.R. (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet., Chapter 7, Unit7.20.
74. Kumar, P., Henikoff, S. and Ng, P.C. (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc., 4, 1073-1081.
75. Li, B., Krishnan, V.G., Mort, M.E., Xin, F., Kamati, K.K., Cooper, D.N., Mooney, S.D. and Radivojac, P. (2009) Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics, 25, 2744-2750.
76. Arnold, M., Raffler, J., Pfeufer, A., Suhre, K. and Kastenmüller, G. (2015) SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics, 31, 1334-1336.